Medical Net, Inc. (TYO:3645)
Japan
· Delayed Price · Currency is JPY 306.00
+1.00 (0.33%)
Jul 9, 2025, 3:30 PM JST
Medical Net Income Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2015 - 2019 |
| 6,018 | 5,252 | 4,500 | 3,745 | 3,330 | 2,917 | Upgrade
| |
Revenue Growth (YoY) | 19.64% | 16.71% | 20.16% | 12.46% | 14.16% | 30.46% | Upgrade
|
Cost of Revenue | 4,030 | 3,411 | 2,720 | 2,285 | 2,153 | 1,945 | Upgrade
|
Gross Profit | 1,988 | 1,841 | 1,780 | 1,460 | 1,177 | 972 | Upgrade
|
Selling, General & Admin | 1,844 | 1,524 | 1,396 | 1,000 | 845 | 859 | Upgrade
|
Operating Expenses | 1,861 | 1,542 | 1,401 | 1,010 | 846 | 866 | Upgrade
|
Operating Income | 127 | 299 | 379 | 450 | 331 | 106 | Upgrade
|
Interest Expense | -11 | -6 | -3 | -1 | -1 | -2 | Upgrade
|
Interest & Investment Income | 3 | 1 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 31 | 34 | 45 | 8 | 2 | - | Upgrade
|
Other Non Operating Income (Expenses) | 10 | -7 | 10 | -5 | 3 | -1 | Upgrade
|
EBT Excluding Unusual Items | 160 | 321 | 431 | 452 | 335 | 103 | Upgrade
|
Gain (Loss) on Sale of Investments | - | -4 | -40 | 84 | -81 | - | Upgrade
|
Gain (Loss) on Sale of Assets | 3 | 5 | 2 | - | - | - | Upgrade
|
Asset Writedown | -212 | -170 | -143 | - | - | - | Upgrade
|
Other Unusual Items | -8 | -1 | - | - | -1 | - | Upgrade
|
Pretax Income | -57 | 151 | 250 | 536 | 253 | 103 | Upgrade
|
Income Tax Expense | 96 | 126 | 141 | 137 | 116 | 20 | Upgrade
|
Earnings From Continuing Operations | -153 | 25 | 109 | 399 | 137 | 83 | Upgrade
|
Minority Interest in Earnings | -33 | -20 | 7 | -15 | -8 | -4 | Upgrade
|
Net Income | -186 | 5 | 116 | 384 | 129 | 79 | Upgrade
|
Net Income to Common | -186 | 5 | 116 | 384 | 129 | 79 | Upgrade
|
Net Income Growth | - | -95.69% | -69.79% | 197.67% | 63.29% | -22.55% | Upgrade
|
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 8 | 9 | Upgrade
|
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 8 | 9 | Upgrade
|
Shares Change (YoY) | -0.49% | 0.94% | 2.40% | 3.65% | -1.53% | -20.41% | Upgrade
|
EPS (Basic) | -20.66 | 0.55 | 12.95 | 43.88 | 15.28 | 9.21 | Upgrade
|
EPS (Diluted) | -20.66 | 0.55 | 12.95 | 43.88 | 15.28 | 9.21 | Upgrade
|
EPS Growth | - | -95.73% | -70.50% | 187.19% | 65.83% | -2.68% | Upgrade
|
Free Cash Flow | - | 87 | 410 | 340 | 378 | 70 | Upgrade
|
Free Cash Flow Per Share | - | 9.62 | 45.76 | 38.85 | 44.77 | 8.16 | Upgrade
|
Dividend Per Share | 3.000 | 3.000 | 2.500 | 2.500 | 2.500 | 0.750 | Upgrade
|
Dividend Growth | 20.00% | 20.00% | - | - | 233.33% | -25.00% | Upgrade
|
Gross Margin | 33.03% | 35.05% | 39.56% | 38.98% | 35.34% | 33.32% | Upgrade
|
Operating Margin | 2.11% | 5.69% | 8.42% | 12.02% | 9.94% | 3.63% | Upgrade
|
Profit Margin | -3.09% | 0.10% | 2.58% | 10.25% | 3.87% | 2.71% | Upgrade
|
Free Cash Flow Margin | - | 1.66% | 9.11% | 9.08% | 11.35% | 2.40% | Upgrade
|
EBITDA | 174 | 352 | 440 | 479 | 355 | 125 | Upgrade
|
EBITDA Margin | 2.89% | 6.70% | 9.78% | 12.79% | 10.66% | 4.29% | Upgrade
|
D&A For EBITDA | 47 | 53 | 61 | 29 | 24 | 19 | Upgrade
|
EBIT | 127 | 299 | 379 | 450 | 331 | 106 | Upgrade
|
EBIT Margin | 2.11% | 5.69% | 8.42% | 12.02% | 9.94% | 3.63% | Upgrade
|
Effective Tax Rate | - | 83.44% | 56.40% | 25.56% | 45.85% | 19.42% | Upgrade
|
Advertising Expenses | - | 119 | 119 | 108 | 72 | 131 | Upgrade
|
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.